Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €742 million turnover
-
-€121 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€742 million)- 108th in Top Companies
- 17th in Health
- 17th in Pharma
By Employees
(2,000)- 114th in Top Companies
- 18th in Health
- 7th in Pharma
-
- 2,000
- €742 million
Employees
- James Burke Director
Latest News
- 12:30am Meat consumption must drop by 90% to avert climate crisis, report warns
- 12:22am JobPath scheme a dead end for unemployed, claim experts
- Jan 16 Judge prevents receivers taking possession of Kilmacthomas Workhouse
- Jan 16 Dublin Airport seeks contractors for €1bn worth of work
- Jan 16 $18.5m fundraise for cybersecurity group with Irish founder